Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teligent Announces $140m Operating Loss As Plant Woes Continue
Sales Drop By A Third After Challenging 12 Months
May 06 2021
•
By
Dean Rudge
Teligent has revealed the full impact of the FDA Warning Letter on its operations • Source: Shutterstock
More from Earnings
More from Business